Search
Loading search results...
Search Results for "IXICO end with strong financial year, with focus on ageing population and need for new treatments"
IXICO end with strong financial year, with focus on ageing population and need for new treatments
IXICO
IXICO PLC - Investor Presentation
IXICO chosen to provide services for second Alzheimer’s clinical trial in the span of one week
IXICO CEO Giulio Cerroni on record revenues and significant contract expansion
LEAP by IXICO | Advancing Imaging Operations & Analysis in Alzheimer’s Disease Clinical Trials
IXICO (IXI) - Giulio Cerroni, CEO & Grant Nash, CFO
4d pharma reveal positive data from phase II trial of treatment for Irritable Bowel Syndrome
Faron Pharmaceuticals Oy excited by green light for trials of promising anti-cancer treatment
Bango delivers revenue growth ahead of expectations
Pantheon International PLC reports strong performance, supported by valuation gains
Sensyne Health 'achieves primary IPO objective' with a database with over 5m records.